NRG Oncology guideline for proton therapy in multi-institutional trials recommends robustness evaluation on the clinical target volume using worst-case scenarios instead of photon-style PTV margins, plus central collection of beam model and LET data.
Guideline
Liang et al. Technical Considerations on Proton Therapy in NRG's Multi-Institutional Clinical Trials